May 19, 2026 08:30PM
May 19, 2026 08:30PM
Feb 23, 2026 09:36AM
Dec 21, 2025 04:00AM
Mar 25, 2024 08:21AM
Feb 5, 2024 09:08AM
Feb 5, 2024 09:00AM ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the 71% Complete Responders Suggesting a Favorable Risk-Benefit Ratio for N-803 Plus
Jan 2, 2024 06:00AM
Jan 2, 2024 06:00AM
Oct 26, 2023 09:02AM
Oct 26, 2023 09:00AM
Apr 25, 2023 09:00AM
Apr 24, 2023 11:28PM
Mar 20, 2023 08:49AM ImmunityBio (IBRX) Provides Update on BLA for N-803
Feb 16, 2023 09:00AM
Feb 15, 2023 09:00AM
Feb 15, 2023 09:00AM
Jan 19, 2023 09:00AM
Jul 28, 2022 04:19PM
Jul 28, 2022 04:18PM
Mar 25, 2021 08:00AM CytRx Comments on Fiscal Year 2020 Results and Highlights Strategic Progress

15,464 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All